P.0886 Cannabinoids in the prevention of behavioral and brain deficits in a schizophrenia-like rat model

  1. Rama, N. Lamanna 1
  2. Romero-Miguel, D. 1
  3. Casquero-Veiga, M. 1211
  4. Gómez-Rangel, V. 1
  5. Luengo-Arias, S. 1
  6. Gálvez, C. 35
  7. Santa-Marta, C. 12
  8. Torres-Sanchez, S. 8910
  9. Berrocoso, E. 8910
  10. Desco, M. 121314
  11. Abalo, R. 3567
  12. Soto-Montenegro, M.L. 1234
  1. 1 Instituto de Investigación Sanitaria Gregorio Marañón, Preclinical Neuroimaging Group - Medical Imaging Laboratory, Madrid, Spain.
  2. 2 CIBER de Salud Mental, Group 07, Madrid, Spain.
  3. 3 Universidad Rey Juan Carlos, High Performance Research Group in Physiopathology and Pharmachology of the Digestive System, Alcorcón, Spain.
  4. 4 Spanish Pain Society, Working Group of Basic Science in Pain og Analgesia, Madrid, Spain.
  5. 5 Universidad Rey Juan Carlos, Department of Basic Health Science, Alcorcón, Spain.
  6. 6 Scientific Research Superior Council, Associated I+D+i Unit to the Institute of Medicinal Chemistry, Alcorcón, Spain.
  7. 7 Spanish Pain Society, Working Group of Basic Science in Pain of Analgesia, Madrid, Spain.
  8. 8 Universidad de Cádiz, Neuropsychopharmachology & Psychobiology Research Group - Psychobiology Area - Department of Psychology, Puerto Real- Cádiz, Spain.
  9. 9 CIBER de Salud Mental, Group 18, Madrid, Spain.
  10. 10 Hospital Universitario Puerta del Mar, Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz, Cádiz, Spain.
  11. 11 Centro Nacional de Investigaciones Cardiovasculares, Cardiovascular Imaging and Population tudies Group, Madrid, Spain.
  12. 12 Universidad Nacional de Educación a Distancia, Department of Physical Mathematics and Fluids, Madrid, Spain.
  13. 13 Universidad Carlos III de Madrid, Bioengineering and Aerospatial Ingeniery Department, Leganés, Spain.
  14. 14 Centro Nacional de Investigaciones Cardiovasculares, Advanced Imaging Unit, Madrid, Spain.
Revista:
European Neuropsychopharmacology

ISSN: 0924-977X

Año de publicación: 2021

Volumen: 53

Páginas: S649-S650

Tipo: Artículo

DOI: 10.1016/J.EURONEURO.2021.10.742 GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: European Neuropsychopharmacology

Referencias bibliográficas

  • Upthegrove, (2020), Curr Top Behav Neurosci, 44, pp. 49, 10.1007/7854_2018_88
  • Jenkins, (2021), Front Psychiatry, 12, 10.3389/fpsyt.2021.597725
  • Meyer, (2013), Prog Neuropsychopharmacol Biol Psychiatry, 42, pp. 20, 10.1016/j.pnpbp.2011.11.003
  • Casquero-Veiga, (2019), Eur Neuropsychopharmacol, 29, pp. 880, 10.1016/j.euroneuro.2019.05.002
  • Hadar, (2015), Schizophr Res, 166, pp. 238, 10.1016/j.schres.2015.05.010